HomeCompareZNWLF vs JNJ

ZNWLF vs JNJ: Dividend Comparison 2026

ZNWLF yields 4000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZNWLF wins by $7175340620755.84M in total portfolio value
10 years
ZNWLF
ZNWLF
● Live price
4000.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7175340620755.87M
Annual income
$6,839,006,593,197,835,000.00
Full ZNWLF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ZNWLF vs JNJ

📍 ZNWLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZNWLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZNWLF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZNWLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZNWLF
Annual income on $10K today (after 15% tax)
$340,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,813,155,604,218,160,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ZNWLF beats the other by $5,813,155,604,218,156,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZNWLF + JNJ for your $10,000?

ZNWLF: 50%JNJ: 50%
100% JNJ50/50100% ZNWLF
Portfolio after 10yr
$3587670310377.95M
Annual income
$3,419,503,296,598,920,000.00/yr
Blended yield
95.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ZNWLF
No analyst data
Altman Z
7.1
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZNWLF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZNWLFJNJ
Forward yield4000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$7175340620755.87M$30.3K
Annual income after 10y$6,839,006,593,197,835,000.00$4,689.40
Total dividends collected$7152397773804.84M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ZNWLF vs JNJ ($10,000, DRIP)

YearZNWLF PortfolioZNWLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$410,700$400,000.00$10,592$272.30+$400.1KZNWLF
2$15,792,720$15,353,271.03$11,289$357.73+$15.78MZNWLF
3$568,657,142$551,758,931.89$12,123$472.89+$568.65MZNWLF
4$19,176,207,860$18,567,744,718.20$13,141$629.86+$19176.19MZNWLF
5$605,696,028,890$585,177,486,479.73$14,408$846.81+$605696.01MZNWLF
6$17,922,210,653,594$17,274,115,902,681.27$16,021$1,151.60+$17922210.64MZNWLF
7$496,869,793,504,300$477,693,028,104,954.00$18,122$1,588.22+$496869793.49MZNWLF
8$12,908,672,105,251,704$12,377,021,426,202,104.00$20,930$2,228.20+$12908672105.23MZNWLF
9$314,330,866,876,668,540$300,518,587,724,049,200.00$24,792$3,191.91+$314330866876.64MZNWLF
10$7,175,340,620,755,871,000$6,839,006,593,197,835,000.00$30,274$4,689.40+$7175340620755.84MZNWLF

ZNWLF vs JNJ: Complete Analysis 2026

ZNWLFStock

Zinnwald Lithium Plc operates as a mineral exploration and development company in the United Kingdom, Ireland, and Germany. It primarily explores for zinc, lead, silver, and lithium deposits. The company's flagship project is the Zinnwald Lithium project covering an area of 256.5 hectare located in southeast Germany. It also holds 100% interests in the Abbeytown project that comprises five prospecting licenses covering approximately 136 square kilometers. The company was formerly known as Erris Resources Plc and changed its name to Zinnwald Lithium Plc in October 2020. Zinnwald Lithium Plc was founded in 2012 and is based in London, the United Kingdom.

Full ZNWLF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ZNWLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZNWLF vs SCHDZNWLF vs JEPIZNWLF vs OZNWLF vs KOZNWLF vs MAINZNWLF vs ABBVZNWLF vs MRKZNWLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.